[HTML][HTML] Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - Anais brasileiros de dermatologia, 2014 - SciELO Brasil
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
[PDF][PDF] Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - An Bras Dermatol, 2014 - pdfs.semanticscholar.org
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - sidalc.net
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
[HTML][HTML] Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - Anais Brasileiros de Dermatologia, 2014 - ncbi.nlm.nih.gov
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
Cutaneous melanoma: new advances in treatment.
MC Foletto, SE Haas - Anais Brasileiros de Dermatologia, 2014 - europepmc.org
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - Anais brasileiros de dermatologia, 2014 - pubmed.ncbi.nlm.nih.gov
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
[PDF][PDF] Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - An Bras Dermatol, 2014 - scienceopen.com
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - An. bras. dermatol, 2014 - pesquisa.bvsalud.org
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
[HTML][HTML] Cutaneous melanoma: new advances in treatment
MC Foletto, SE Haas - Anais Brasileiros de Dermatologia, 2014 - SciELO Brasil
Cutaneous melanoma is a challenge to treat. Over the last 30 years, no drug or combination
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …
of drugs demonstrated significant impact to improve patient survival. From 1995 to 2000, the …